Alvarez-Mon M - Search Results

1

Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3.

Merino F, Alvarez-Mon M, de la Hera A, Alés JE, Bonilla F, Durantez A. Merino F, et al. Cell Immunol. 1989 Feb;118(2):328-36. doi: 10.1016/0008-8749(89)90381-x. Cell Immunol. 1989. PMID: 2783392

2

Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis.

Menéndez JL, Girón JA, Manzano L, Garrido A, Abreu L, Albillos A, Durántez A, Alvarez-Mon M. Menéndez JL, et al. Hepatology. 1992 Oct;16(4):931-6. doi: 10.1002/hep.1840160413. Hepatology. 1992. PMID: 1398499

3

Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients.

Girón JA, Alvarez-Mon M, Menéndez-Caro JL, Abreu L, Albillos A, Manzano L, Durántez A. Girón JA, et al. Hepatology. 1992 Sep;16(3):664-70. doi: 10.1002/hep.1840160309. Hepatology. 1992. PMID: 1505909

4

Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.

Manzano L, Alvarez-Mon M, Abreu L, Antonio Vargas J, de la Morena E, Corugedo F, Duràntez A. Manzano L, et al. Gut. 1992 Feb;33(2):246-51. doi: 10.1136/gut.33.2.246. Gut. 1992. PMID: 1541421 Free PMC article.

5

Analysis of the effect of intravesical treatment with interferon-alpha 2b on the clinical evolution and on the in vivo function of T lymphocytes and natural killer cells in patients with superficial bladder tumors.

Carballido J, Moltó LM, Olivier C, Manzano L, Alvarez-Mon M. Carballido J, et al. Anticancer Drugs. 1992 May;3 Suppl 1:9-12. doi: 10.1097/00001813-199205000-00003. Anticancer Drugs. 1992. PMID: 1611118 Clinical Trial.

6

Two different maturational stages of natural killer lymphocytes in human newborn infants.

Sancho L, de la Hera A, Casas J, Vaquer S, Martínez C, Alvarez-Mon M. Sancho L, et al. J Pediatr. 1991 Sep;119(3):446-54. doi: 10.1016/s0022-3476(05)82061-x. J Pediatr. 1991. PMID: 1715396

7

Pregnancy is associated with a reduction in the pattern of the cytotoxic activity displayed by lymphokine-activated killer cells.

Salméron OJ, Vaquer S, Salmerón I, Moltó L, Lapeña P, Manzano L, de las Heros JI, Alvarez-Mon M. Salméron OJ, et al. Am J Reprod Immunol. 1991 Dec;26(4):150-5. doi: 10.1111/j.1600-0897.1991.tb00716.x. Am J Reprod Immunol. 1991. PMID: 1840730

8

Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma.

Lapeña P, Isasi C, Vaquero J, Martinez R, Alvarez-Mon M. Lapeña P, et al. Acta Neurochir (Wien). 1991;109(3-4):109-13. doi: 10.1007/BF01403004. Acta Neurochir (Wien). 1991. PMID: 1858528

9

Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.

Carballido J, Alvarez-Mon M, Solovera OJ, Menéndez-Ondina L, Durántez A. Carballido J, et al. J Urol. 1990 Jan;143(1):29-33. doi: 10.1016/s0022-5347(17)39854-3. J Urol. 1990. PMID: 2294256

10

Natural killer activity in patients with breast cancer.

Bonilla F, Alvarez-Mon M, Merino F, Girón JA, Menéndez JL, Espana P, Durántez A. Bonilla F, et al. Eur J Gynaecol Oncol. 1990;11(2):103-9. Eur J Gynaecol Oncol. 1990. PMID: 2379508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

449 results

Search Page

Filters